George Medicines 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
amlodipine/indapamide/telmisartan (GMRx2) / George Medicines
2020-004196-40: Efficacy and safety of GMRx2 compared to dual combinations for the treatment of high blood pressure Účinnost a bezpečnost GMRx2 ve srovnání s duálními kombinacemi při léčbě vysokého krevního tlaku

Not yet recruiting
3
1500
RoW, Europe
Triple TAI (GMRx2) Dose Version 2, Triple - TAI (GMRx2) Dose Version 3, Dual - TA Telmisartan / Amlodipine, Dual - TI Telmisartan / Indapamide, Dual - AI Amlodipine / Indapamide, Triple TAI (GMRx2) Dose Version 2, Triple - TAI (GMRx2) Dose Version 3, Dual - TA Telmisartan / Amlodipine, Dual - TI Telmisartan / Indapamide, Dual - AI Amlodipine / Indapamide, Capsule
George Medicines Pty Ltd, George Medicines
Hypertension, High blood pressure, Diseases [C] - Cardiovascular Diseases [C14]
 
 
GMRx2_PCT, NCT04518306: Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension

Completed
3
755
Europe, US, RoW
Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg, Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg, Placebo
George Medicines PTY Limited
Hypertension
09/23
10/23
GMRx2_ACT, NCT04518293: Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension

Completed
3
1385
Europe, US, RoW
Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg, telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg, Telmisartan 20 mg/amlodipine 2.5 mg, telmisartan 40 mg/amlodipine 5 mg, Telmisartan 20 mg/indapamide 1.25 mg, telmisartan 40 mg/indapamide 2.5 mg, Amlodipine 2.5 mg/indapamide 1.25 mg, amlodipine 5 mg/indapamide 2.5 mg
George Medicines PTY Limited
Hypertension
08/23
09/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
amlodipine/indapamide/telmisartan (GMRx2) / George Medicines
2020-004196-40: Efficacy and safety of GMRx2 compared to dual combinations for the treatment of high blood pressure Účinnost a bezpečnost GMRx2 ve srovnání s duálními kombinacemi při léčbě vysokého krevního tlaku

Not yet recruiting
3
1500
RoW, Europe
Triple TAI (GMRx2) Dose Version 2, Triple - TAI (GMRx2) Dose Version 3, Dual - TA Telmisartan / Amlodipine, Dual - TI Telmisartan / Indapamide, Dual - AI Amlodipine / Indapamide, Triple TAI (GMRx2) Dose Version 2, Triple - TAI (GMRx2) Dose Version 3, Dual - TA Telmisartan / Amlodipine, Dual - TI Telmisartan / Indapamide, Dual - AI Amlodipine / Indapamide, Capsule
George Medicines Pty Ltd, George Medicines
Hypertension, High blood pressure, Diseases [C] - Cardiovascular Diseases [C14]
 
 
GMRx2_PCT, NCT04518306: Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension

Completed
3
755
Europe, US, RoW
Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg, Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg, Placebo
George Medicines PTY Limited
Hypertension
09/23
10/23
GMRx2_ACT, NCT04518293: Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension

Completed
3
1385
Europe, US, RoW
Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg, telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg, Telmisartan 20 mg/amlodipine 2.5 mg, telmisartan 40 mg/amlodipine 5 mg, Telmisartan 20 mg/indapamide 1.25 mg, telmisartan 40 mg/indapamide 2.5 mg, Amlodipine 2.5 mg/indapamide 1.25 mg, amlodipine 5 mg/indapamide 2.5 mg
George Medicines PTY Limited
Hypertension
08/23
09/23

Download Options